Skip to main content

Table 4 Early diagnostic tools in MAS complicating sJIA

From: Egyptian evidence-based consensus on clinical practice guidelines for the diagnosis and treat-to-target management of macrophage activation syndrome in children

Statement

LE

SoR

Mean rate± SD

% of agreement

Level of agreement

- Progressive increase in serum ferritin is a valuable laboratory marker showing the largest change in both pre-MAS and MAS-onset values (often > 10,000 ng/mL)

- Dropping ESR levels helps to distinguish MAS from a flare of the underlying rheumatic disorder (where ESR is usually elevate (a drop in ESR or a disproportion between ESR and CRP levels would raise the suspicion of MAS))

- As some patients may have basic elevated serum ferritin levels especially with repeated blood transfusions, a progressive increase in serum ferritin from the basic level for these patients would be suggestive of MAS particularly if it was associated with a decrease of ESR

- Relative decrease in platelet count followed by a decrease in WBCs, or fibrinogen levels rather than an absolute decrease, may be more useful in making an early diagnosis of MAS and differentiate MAS from sJIA flare

- Hemophagocytosis in bone marrow examination is pathognomonic, but failure to reveal hemophagocytosis does not exclude the diagnosis of MAS as histopathologic features of hemophagocytosis may not be present in the initial stages

3

B

8.26 ± 1.7

95.65

H

  1. LE level of evidence according to the Oxford Centre for Evidence-Based Medicine (CEBM) criteria, H high level of agreement, SoR strength of recommendation, MAS macrophage activation syndrome, sJIA systemic onset juvenile idiopathic arthritis, ESR erythrocyte sedimentation rate, CRP C-reactive protein